Interpret this ecg

IMG_20260527_194848483.jpg

Interpret this ecg

Reading File

Finding Sources

Loading Image

Finding Sources

I have a clear view of the ECG. Let me provide the full interpretation now.

ECG Interpretation

Patient: Mrs. Gomati, 63 years old, Female, Non-smoker Facility: Apex Hospital, Jaipur Date: 27-May-2026 Settings: Speed 25 mm/s | Gain 1.00 cm/mV | HF 0.05 Hz | LF 35 Hz | Notch 50 Hz

Systematic Analysis

Rate: 81 bpm (normal)

Rhythm: Regular sinus rhythm - P waves are present and precede each QRS

Axis: The machine notes approximately -30°, which is in the left axis deviation range (borderline/mild LAD)

Intervals (from machine printout):

PR interval: ~172 ms (upper limit of normal; borderline first-degree AV block)
QRS: ~96 ms (normal, <120 ms)
QT/QTc: ~431/~500 ms - QTc is prolonged (>440 ms in females)

Lead-by-Lead Analysis

Limb Leads:

Lead	Finding
I	Upright QRS, positive deflection
II	Positive QRS, visible P waves
III	Small/isoelectric complex
aVR	Negative QRS (expected)
aVL	Positive QRS
aVF	Low-amplitude or biphasic

Precordial Leads:

Lead	Finding
V1	Small r wave, deep S - RSR' pattern not clearly seen
V2	rS morphology
V3	Transition zone
V4	Dominant R wave developing
V5	Tall R wave
V6	Upright R wave

Key Abnormalities Identified:

ST-segment changes: There appear to be ST-T wave abnormalities visible in the precordial leads (V4-V6), with flattening or mild depression - suggesting lateral ischemia or strain pattern.
T-wave changes: Flattened or inverted T waves in the lateral leads (V5-V6, I, aVL) - consistent with lateral ischemic changes or LVH strain.
Left axis deviation (machine-reported at ~-30°): Could represent left anterior fascicular block (LAFB) or inferior infarction.
Prolonged QTc (~500 ms): Significantly prolonged - this is clinically important. Can be drug-induced, electrolyte disturbance (hypokalemia, hypomagnesemia, hypocalcemia), or intrinsic cardiac disease.
Possible LVH criteria: Tall R waves in lateral leads with associated ST-T changes may suggest left ventricular hypertrophy.

Summary / Impression

Sinus rhythm at 81 bpm with:

Left axis deviation (borderline LAFB)

Prolonged QTc (~500 ms) - clinically significant, requires urgent evaluation

ST-T wave abnormalities in lateral leads - possible lateral ischemia or LVH strain pattern

Borderline prolonged PR (possible 1st degree AV block)

Clinical Recommendations

Given this is a 63-year-old woman presenting to hospital:

Prolonged QTc (~500 ms) is the most urgent finding - check electrolytes (K+, Mg2+, Ca2+), review all medications for QT-prolonging drugs (antipsychotics, antibiotics, antiemetics, antiarrhythmics)
Lateral ST-T changes - correlate with symptoms (chest pain, dyspnea, syncope). Obtain serial ECGs and cardiac troponins to rule out ACS
Echo recommended to assess LV function and wall motion abnormalities
Consider cardiology consultation given the combination of QTc prolongation and ischemic-appearing ST-T changes

Disclaimer: This is an AI-assisted interpretation for educational support only. All ECG findings must be reviewed and confirmed by a qualified physician or cardiologist before any clinical decisions are made.

Why oxcarbamazepine is given in Gillian baare syndrome with its MOA

Finding Sources

Reading File

Finding Sources

Reading File

I now have enough information for a thorough answer. Let me also note an important clarification upfront.

Important Clarification First

Oxcarbazepine is NOT a standard or primary treatment for Guillain-Barré Syndrome (GBS). The established treatments for GBS are IVIG (intravenous immunoglobulin) and plasmapheresis (plasma exchange) - these target the underlying autoimmune demyelination. Oxcarbazepine has no role in modifying the course of GBS.

However, oxcarbazepine (and related anticonvulsants) are sometimes used in GBS as adjunct therapy for neuropathic pain, which is a common and often undertreated symptom of GBS.

Why Neuropathic Pain Occurs in GBS

In GBS, the immune-mediated attack on peripheral nerves causes:

Demyelination of peripheral motor and sensory nerves
Axonal damage (in AMAN/AMSAN subtypes)
Ectopic discharge from injured/partially demyelinated nerve fibers
Sensitization of dorsal root ganglion neurons

This results in severe neuropathic pain - burning, shooting, "electric" pain - in up to 55-89% of GBS patients, which can persist even into recovery.

Role of Oxcarbazepine in GBS - For Neuropathic Pain

Oxcarbazepine is an anticonvulsant used off-label as an adjunct analgesic for the neuropathic pain component of GBS, alongside other agents like gabapentin, pregabalin, and tricyclic antidepressants.

Mechanism of Action of Oxcarbazepine

Oxcarbazepine is a keto-derivative (10-keto analog) of carbamazepine, and its active metabolite is 10-monohydroxy derivative (MHD / licarbazepine), which carries out most of the pharmacological action.

Primary MOA: Voltage-Gated Sodium Channel Blockade

Injured/demyelinated nerve fiber
         ↓
Ectopic spontaneous Na⁺ channel firing
         ↓
Oxcarbazepine / MHD binds to the inactivated state
of voltage-gated Na⁺ channels
         ↓
Stabilizes the channel in the INACTIVATED (closed) state
         ↓
Blocks repetitive/high-frequency neuronal firing
         ↓
Reduces ectopic pain impulses from damaged nerve fibers
         ↓
↓ Neuropathic pain

It selectively suppresses high-frequency, repetitive action potentials while leaving normal low-frequency neuronal activity relatively intact (use-dependent/frequency-dependent block)
It slows the rate of recovery of inactivated sodium channels, making them stay closed longer after each depolarization

Secondary MOA: Calcium Channel Modulation

Also modestly inhibits voltage-gated calcium channels, reducing presynaptic neurotransmitter (glutamate, substance P) release at dorsal horn synapses - further dampening central pain sensitization

Advantages Over Carbamazepine in GBS Patients

Feature	Carbamazepine	Oxcarbazepine
Hepatic enzyme induction	Strong (CYP3A4 inducer)	Minimal - does NOT induce hepatic enzymes
Drug-drug interactions	Many (problematic in ICU patients on IVIG, antibiotics, etc.)	Fewer interactions
Tolerability	More side effects	Better tolerated
Active metabolite	Epoxide (toxic)	MHD (safer)

This makes oxcarbazepine preferable in GBS patients who are often critically ill and on multiple medications.

Summary

Aspect	Detail
Why given	Adjunct for neuropathic pain in GBS (NOT for the primary autoimmune disease)
Primary MOA	Blocks voltage-gated Na⁺ channels in inactivated state → suppresses ectopic high-frequency firing from damaged nerves
Secondary MOA	Modest Ca²⁺ channel inhibition → reduces glutamate/substance P release
Net effect	Decreased spontaneous neuronal discharge → reduced burning/shooting neuropathic pain
Preferred over carbamazepine because	Better tolerability, fewer drug interactions, no hepatic enzyme induction

Sources: Bradley and Daroff's Neurology in Clinical Practice; Katzung's Basic and Clinical Pharmacology 16e; Harrison's Principles of Internal Medicine 22e

This is a shared conversation. Sign in to Orris to start your own chat.